Who Benefits from Family Psychoeducation for Relatives of Adults with Major Depressive Disorder? Findings from a Randomized Controlled Trial
Abstract
1. Introduction
2. Methods
2.1. Study Design
2.2. Participants
2.3. Randomization and Blinding
2.4. Interventions
- Intervention group: Family psychoeducationRelatives in the intervention group attended a four-week structured psychoeducation program delivered in small groups of up to six participants. The patients with MDD did not participate in the sessions. Each weekly meeting lasted approximately 120 min and consisted of a brief lecture followed by a longer interactive component. The lecture introduced core topics such as depression, family emotional dynamics, and expressed emotion. The interactive part focused on practicing problem-solving strategies for managing high-emotion situations within the family. Discussions were supported by fictional cases designed to help participants apply the material to their own everyday challenges.Sessions were facilitated by psychiatric nurses or psychologists experienced in delivering manualized psychoeducation for mood disorders. Two group leaders conducted each psychoeducation group. The program drew partly on the McFarlane multifamily model [10] and on existing research on reducing expressed emotion, with particular attention to criticism as a key element in families affected by unipolar depression.
- Control group: Social-support meetingsRelatives assigned to the control condition attended four group meetings matching the intervention group in duration and overall structure but without psychoeducational content. The meetings provided a moderated forum for sharing experiences with other families. The group leader acted as facilitator rather than instructor and did not present any structured material, although participants could request suggestions for discussion topics. Each group was led by one trained clinician. After each session, the facilitator recorded the themes discussed.
2.5. Quality Assurance
2.6. Outcome Measures
2.7. Assessment Schedule
2.8. Statistical Analysis
2.9. Ethical Considerations
3. Results
3.1. Study Characteristics
3.2. Effects on Primary Outcomes
3.3. Subgroup Analyses
3.3.1. Gender
3.3.2. Age
3.3.3. Relationship to the Patient
3.3.4. Previous Psychiatric Treatment
3.4. Summary
4. Discussion
4.1. Comparison with Other Studies
4.2. Strengths and Limitations
4.3. Clinical and Research Perspectives
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Pasman, J.A.; Meijsen, J.J.; Haramd, M.; Kowaleca, K.; Hardera, A.; Xionga, Y.; Nguyena, T.-D.; Jangmoa, A.; Shorter, J.R.; Bergstedt, J.; et al. Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers. Lancet Reg. Health Eur. 2023, 29, 100621. [Google Scholar] [CrossRef] [PubMed]
- Yao, H.; Li, K.; Li, C.; Hu, S.; Huang, Z.; Chen, J.; Xu, Y. Caregiving burden; depression, and anxiety in informal caregivers of people with mental illness in China: A cross-sectional survey. BMC Psychiatry 2024, 24, 824. [Google Scholar] [CrossRef] [PubMed]
- Buus, N.; Petersen, A.; McPherson, S.; Meadows, G.; Brand, G.; Ong, B. The relatives of people with depression: A systematic review and methodological critique of qualitative studies. Fam. Process 2023, 63, 1469–1483. [Google Scholar] [CrossRef] [PubMed]
- Cole, A.; Pooley, J.A.; Whitehead, L. Family members’ experiences with depression through the lens of Frank’s illness narratives. Collegian 2024, 31, 392–403. [Google Scholar] [CrossRef]
- Sampogna, G.; Brohan, E.; Luciano, M.; Chowdhary, N.; Fiorillo, A. Psychosocial interventions for carers of people with severe mental and substance use disorders: A systematic review and meta-analysis. Eur. Psychiatry 2023, 66, e98. [Google Scholar] [CrossRef] [PubMed]
- Rodolico, A.; Bighelli, I.; Avanzato, C.; Concerto, C.; Cutrufelli, P.; Mineo, L.; Schneider-Thoma, J.; Siafis, S.; Signorelli, M.S.; Wu, H.; et al. Family interventions for relapse prevention in schizophrenia: A systematic review and network meta-analysis. Lancet Psychiatry 2022, 9, 211–221. [Google Scholar] [CrossRef] [PubMed]
- Katsuki, F.; Watanabe, N.; Yamada, A.; Hasegawa, T. Effectiveness of family psychoeducation for major depressive disorder: Systematic review and meta-analysis. BJPsych Open 2022, 8, e148. [Google Scholar] [CrossRef] [PubMed]
- Katsuki, F.; Takeuchi, H.; Inagaki, T.; Maeda, T.; Kubota, Y.; Shiraishi, N.; Tabuse, H.; Kato, T.; Yamada, A.; Watanabe, N.; et al. Brief multifamily Psychoeducation for family members of patients with chronic major depression: A randomized controlled trial. BMC Psychiatry 2018, 18, 207. [Google Scholar] [CrossRef] [PubMed]
- Timmerby, N.; Austin, S.F.; Ussing, K.; Bech, P.; Csillag, C. Family psychoeducation for major depressive disorder—Study protocol for a randomized controlled trial. Trials 2016, 17, 427. [Google Scholar] [CrossRef] [PubMed]
- McFarlane, W.R. Multifamily Groups in the Treatment of Severe Psychiatric Disorders; The Guilford Press: New York, NY, USA, 2002. [Google Scholar]
- Brady, P.; Kangas, M.; McGill, K. “Family matters”: A systematic review of the evidence for family psychoeducation for major depressive disorder. J. Marital. Fam. Ther. 2016, 43, 245–263. [Google Scholar] [CrossRef] [PubMed]
- Topp, C.W.; Østergaard, S.D.; Søndergaard, S.; Bech, P. The WHO-5 Well-Being Index: A systematic review of the literature. Psychother. Psychosom. 2015, 84, 167–176. [Google Scholar] [CrossRef] [PubMed]
- Kavanagh, D.J.; O’Halloran, P.; Manicavasagar, V.; Clark, D.; Piatkowska, O.; Tennant, C.; Rosen, A. The family attitude scale: Reliability and validity of a new scale for measuring the emotional climate of families. Psychiatry Res. 1997, 70, 185–195. [Google Scholar] [CrossRef] [PubMed]
- Miller, I.W.; Epstein, N.B.; Bishop, D.S.; Keitner, G.I. The McMaster Family Assesment Device Reliability and Validity. J. Marital. Fam. Ther. 1985, 11, 345–356. [Google Scholar] [CrossRef]
- Rosenman, R.; Tennekoon, V.; Hill, L.G. Measuring bias in self-reported data. Int. J. Behav. Healthc. Res. 2011, 2, 320–332. [Google Scholar] [CrossRef] [PubMed]
- Surra, C.A.; Curran, M.A.; Williams, K. Effects of participation in a longitudinal study of dating. Pers. Relationships 2009, 16, 1–21. [Google Scholar] [CrossRef]
- Kasenda, B.; Schandelmaier, S.; Sun, X.; Elm, E.V.; You, J.; Blümle, A.; Tomonaga, Y.; Saccilotto, R.; Amstutz, A.; Bengough, T.; et al. Subgroup analyses in randomised controlled trials: Cohort study on trial protocols and journal publications. Br. Med. J. 2014, 349, g4539. [Google Scholar] [CrossRef] [PubMed]
- Pomeroy, E.; Fiori, F. Competing demands on adult children: How do they shape their provision of informal care? SSM-Popul. Health 2025, 29, 101754. [Google Scholar] [CrossRef] [PubMed]
- Martire, L.M.; Schulz, R.; Helgeson, V.S.; Small, B.J.; Saghafi, E.M. Review and Meta-analysis of Couple-Oriented Interventions for Chronic Illness. Ann. Behav. Med. 2010, 40, 325–342. [Google Scholar] [CrossRef] [PubMed]
- Furnham, A.; Sjokvist, P. Empathy and Mental Health Literacy. Health Lit. Res. Pract. 2017, 1, e31–e40. [Google Scholar] [CrossRef]




| Baseline | Post Intervention | 9 Months Follow-Up | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Randomization Group | Control Group (n = 46) | Intervention Group (n = 42) | p-Value | Control Group (n = 34) | Intervention Group (n = 37) | p-Value | Control Group (n = 27) | Intervention Group (n = 24) | p-Value |
| Sociodemographic: | |||||||||
| Age, mean (s.d.) | 45.30 (11.7) | 49.2 (13.5) | 0.162 | * | * | * | * | * | * |
| Sex, female, n (%) | 25 (54.30) | 25 (58.10) | 0.719 | * | * | * | * | * | * |
| Education years, mean (s.d.) | 16.36 (3.08) | 15.71 (2.67) | 0.292 | * | * | * | * | * | * |
| Education level, non-tertiary education, n (%) | 10 (21.74) | 8 (18.60) | 0.713 | * | * | * | * | * | * |
| Education level, tertiary education, n (%) | 36 (78.26) | 35 (81.40) | 0.713 | * | * | * | * | * | * |
| History of psychiatric treatment, n (%) | 8 (17.40) | 13 (30.23) | 0.192 | * | * | * | * | * | * |
| Employed or in education, n (%) | 40 (86.96) | 39 (90.70) | 0.203 | * | * | * | * | * | * |
| Not in employment, n (%) | 6 (13.04) | 4 (9.30) | 0.203 | * | * | * | * | * | * |
| Previously attended family support groups, n (%) | 2 (4.30) | 0 (0.00) | 0.167 | * | * | * | * | * | * |
| Relation to patient: | |||||||||
| Relation to patient, parent, n (%) | 15 (32.60) | 16 (37.21) | 0.649 | * | * | * | * | * | * |
| Relation to patient, child, n (%) | 0 (0.00) | 3 (7.00) | 0.068 | * | * | * | * | * | * |
| Relation to patient, sibling, n (%) | 2 (4.35) | 3 (6.98) | 0.590 | * | * | * | * | * | * |
| Relation to patient, spouse/partner, n (%) | 28 (46.50) | 20 (60.90) | 0.174 | * | * | * | * | * | * |
| Relation to patient, grandparent, n (%) | 1 (2.30) | 1 (2.20) | 0.298 | * | * | * | * | * | * |
| Well-being and functioning: | |||||||||
| WHO-5 well-being, total score, mean (s.d.) | 63.57 (13.86) | 64.93 (17.02) | 0.680 | 68.33 (15.43) | 68.86 (17.55) | 0.891 | 65.78 (17.80) | 73.83 (11.19) | 0.062 |
| WHO-5 well-being, item 1 “cheerful mood”, mean (s.d.) | 3.46 (0.75) | 3.62 (0.85) | 0.345 | 3.53 (0.84) | 3.76 (0.95) | 0.282 | 3.48 (0.94) | 3.83 (0.48) | 0.104 |
| WHO-5 well-being, item 2 “calm and relaxed”, mean (s.d.) | 3.20 (0.86) | 3.33 (1.05) | 0.502 | 3.22 (0.96) | 3.43 (1.07) | 0.380 | 3.19 (1.04) | 3.88 (0.54) | 0.005 |
| WHO-5 well-being, item 3 “active and vigorous”, mean (s.d.) | 3.00 (0.87) | 3.11 (0.99) | 0.550 | 3.47 (0.94) | 3.43 (0.80) | 0.846 | 3.15 (1.03) | 3.07 (1.24) | 0.025 |
| WHO-5 well-being, item 4 “rested on waking”, mean (s.d.) | 2.98 (1.20) | 2.86 (1.28) | 0.648 | 3.28 (1.06) | 3.24 (0.95) | 0.884 | 3.07 (1.24) | 3.42 (1.10) | 0.304 |
| WHO-5 well-being, item 5 “interest in daily life”, mean (s.d.) | 3.28 (1.00) | 3.29 (1.09) | 0.989 | 3.61 (0.96) | 3.54 (0.87) | 0.743 | 3.44 (0.97) | 3.63 (0.77) | 0.470 |
| FAD, problem solving, mean (s.d.) | 1.85 (0.41) | 1.77 (0.51) | 0.590 | 1.76 (0.50) | 1.92 (0.34) | 0.235 | 1.70 (0.45) | 1.66 (0.72) | 0.868 |
| FAD, communication, mean (s.d.) | 2.49 (0.28) | 2.44 (0.22) | 0.473 | 2.49 (0.24) | 2.51 (0.19) | 0.782 | 2.44 (0.22) | 2.56 (0.25) | 0.094 |
| FAD, affective responsiveness, mean, (s.d.) | 2.62 (0.37) | 2.62 (0.28) | 0.995 | 2.63 (0.40) | 2.73 (0.26) | 0.352 | 2.73 (0.22) | 2.75 (0.27) | 0.791 |
| FAD, affective involvement, mean (s.d.) | 3.28 (0.43) | 3.32 (0.51) | 0.746 | 3.46 (0.51) | 3.20 (0.60) | 0.137 | 3.57 (0.30) | 3.57 (0.69) | 0.991 |
| FAD, general functioning, mean (s.d.) | 2.35 (0.13) | 2.43 (0.15) | 0.055 | 2.38 (0.17) | 2.44 (1.18) | 0.203 | 2.39 (0.19) | 2.40 (0.20) | 0.769 |
| FAS, total score, mean (s.d.) | 25.52 (13.66) | 25.02 (11.82) | 0.857 | 19.34 (15.03) | 23.86 (12.44) | 0.168 | 23.14 (19.50) | 19.96 (9.66) | 0.345 |
| Psychiatric symptom burden: | |||||||||
| SCL-90, GSI, mean (s.d.) | 0.55 (0.41) | 0.53 (0.39) | 0.861 | * | * | * | * | * | * |
| SCL-90, somatization, mean (s.d) | 0.54 (0.51) | 0.54 (0.51) | 0.992 | * | * | * | * | * | * |
| SCL-90, anxiety, mean (s.d) | 0.34 (0.37) | 0.39 (0.41) | 0.552 | * | * | * | * | * | * |
| SCL-90, interpersonal sensitivity, mean (s.d) | 0.57 (0.54) | 0.56 (0.36) | 0.968 | * | * | * | * | * | * |
| SCL-90, phobic anxiety, mean (s.d) | 0.15 (0.21) | 0.16 (0.20) | 0.799 | * | * | * | * | * | * |
| SCL-90, obsessive cumpulsive, mean (s.d) | 0.75 (0.66) | 0.68 (0.53) | 0.569 | * | * | * | * | * | * |
| SCL-90, depression, mean (s.d) | 0.85 (0.64) | 0.75 (0.60) | 0.492 | * | * | * | * | * | * |
| SCL-90, anger hostility, mean (s.d) | 0.42 (0.40) | 0.34 (0.29) | 0.325 | * | * | * | * | * | * |
| SCL-90, paranoid ideation, mean (s.d) | 0.34 (0.42) | 0.28 (0.44) | 0.482 | * | * | * | * | * | * |
| SCL-90, psychoticism, mean (s.d) | 0.28 (0.40) | 0.23 (0.27) | 0.492 | * | * | * | * | * | * |
| Time: Baseline → Postintervention p#: p-Value for Time Alone p: p-Value for Time by Treatment Groups | Time: Postintervention → 9 Months Follow-Up p#: p-Value for Time Alone p: p-Value for Time by Treatment Groups | Time: Baseline → 9 Months Follow-Up p#: p-Value for Time Alone p: p-Value for Time by Treatment Groups | Time: Baseline → Postintervention → 9 Months Follow-Up p#: p-Value for Time Alone p: p-Value for Time by Treatment Groups | |||||
|---|---|---|---|---|---|---|---|---|
| Outcome | Model 1 (Unadjusted) | Model 2 (Adjusted) | Model 1 (Unadjusted) | Model 2 (Adjusted) | Model 1 (Unadjusted) | Model 2 (Adjusted) | Model 1 (Unadjusted) | Model 2 (Adjusted) |
| WHO well-being scale total score | p# = 0.074, F = 3.284 p = 0.736, F = 3.284 | p# = 0.873, F = 0.026 p = 0.869, F = 0.027 | p# = 0.675, F = 0.178 p = 0.675, F = 0.178 | p# = 0.528, F = 0.406 p = 0.660, F = 0.196 | p# = 0.316, F = 1.028 p = 0.532, F = 0.396 | p# = 0.480, F = 0.508 p = 0.741, F = 0.111 | p# = 0.390, F = 0.943 p = 0.868, F = 0.132 | p# = 0.693, F = 0.355 p = 0.867, F = 0.133 |
| WHO-5 item 1 | p# = 0.334, F = 0.947 p = 0.890, F = 0.019 | p# = 0.921, F = 0.010 p = 0.738, F = 0.113 | p# = 0.471, F = 0.530 p = 0.179, F = 1.872 | p# = 0.865, F = 0.029 p = 0.229, F = 1.491 | p# = 0.951, F = 0.004 p = 0.297, F = 1.109 | p# = 0.274, F = 1.225 p = 0.148, F = 2.168 | p# = 0.548, F = 0.592 p = 0.178, F = 1.768 | p# = 0.649, F = 0.417 p = 0.223, F = 1.532 |
| WHO-5 item 2 | p# = 0.467, F = 0.534 p = 1.000, F = 0.000 | p# = 0.321, F = 0.998 p = 0.750, F = 0.102 | p# = 0.615, F = 0.257 p = 0.983, F = 0.000 | p# = 0.912, F = 0.012 p = 0.964, F = 0.002 | p# = 0.698, F = 0.152 p = 0.206, F = 1.645 | p# = 0.766, F = 0.089 p = 0.276, F = 1.216 | p# = 0.813, F = 0.174 p = 0.765, F = 0.231 | p# = 0.899, F = 0.080 p = 0.773, F = 0.218 |
| WHO-5 item 3 | p# = 0.007, F = 7.742 p = 0.450, F = 0.576 | p# = 0.721, F = 0.129 p = 0.521, F = 0.417 | p# = 0.461, F = 0.554 p = 0.461, F = 0.554 | p# = 0.629, F = 0.237 p = 0.517, F = 0.427 | p# = 0.099, F = 2.835 p = 0.454, F = 0.570 | p# = 0.781, F = 0.078 p = 0.421, F = 0.660 | p# = 0.119, F = 2.201 p = 0.792, F = 0.221 | p# = 0.823, F = 0.196 p = 0.808, F = 0.202 |
| WHO-5 item 4 | p# = 0.169, F = 1.929 p = 0.554, F = 0.354 | p# = 0.387, F = 0.759 p = 0.585, F = 0.301 | p# = 0.470, F = 0.531 p = 0.618, F = 0.253 | p# = 0.246, F = 1.387 p = 0.486, F = 0.494 | p# = 0.578, F = 0.313 p = 0.105, F = 2.725 | p# = 0.508, F = 0.445 p = 0.295, F = 1.124 | p# = 0.310, F = 1.186 p = 0.298, F = 1.227 | p# = 0.477, F = 0.747 p = 0.334, F = 1.111 |
| WHO-5 item 5 | p# = 0.163, F = 1.987 p = 0.702, F = 0.148 | p# = 0.543, F = 0.374 p = 0.798, F = 0.066 | p# = 0.692, F = 0.159 p = 0.907, F = 0.014 | p# = 0.877, F = 0.024 p = 0.759, F = 0.096 | p# = 0.566, F = 0.333 p = 0.794, F = 0.069 | p# = 0.751, F = 0.102 p = 0.967, F = 0.002 | p# = 0.865, F = 0.130 p = 0.894, F = 0.099 | p# = 0.742, F = 0.282 p = 0.810, F = 0.195 |
| Family attitude scale | p# = 0.010, F = 7.023 p = 0.147, F = 2.149 | p# = 0.640, F = 0.221 p = 0.280, F = 1.186 | p# = 0.328, F = 0.978 p = 0.292, F = 1.136 | p# = 0.564, F = 0.338 p = 0.355, F = 0.875 | p# = 0.328, F = 0.978 p = 0.292, F = 1.136 | p# = 0.564, F = 0.338 p = 0.355, F = 0.875 | p# = 0.175, F = 1.818 p = 0.163, F = 1.897 | p# = 0.699, F = 0.307 p = 0.257, F = 1.379 |
| FAD (family assessment device) problem-solving | p# = 0.970, F = 0.001 p = 0.129, F = 2.406 | p# = 0.116, F = 2.593 p = 0.110, F = 2.689 | p# = 0.703, F = 0.150 p = 0.501, F = 0.470 | p# = 0.599, F = 0.287 p = 0.345, F = 0.940 | p# = 0.325, F = 0.967 p = 0.704, F = 0.148 | p# = 0.671, F = 0.186 p = 0.921, F = 0.010 | p# = 0.613, F = 0.335 p = 0.504, F = 0.541 | p# = 0.427, F = 0.707 p = 0.407, F = 0.769 |
| FAD communication | p# = 0.531, F = 0.399 p = 0.630, F = 0.235 | p# = 0.068, F = 3.543 p = 0.704, F = 0.147 | p# = 0.527, F = 0.413 p = 0.039, F = 4.834 | p# = 0.485, F = 0.508 p = 0.084, F = 3.337 | p# = 0.942, F = 0.005 p = 0.096, F = 2.996 | p# = 0.647, F = 0.215 p = 0.099, F = 2.980 | p# = 0.862, F = 0.149 p = 0.115, F = 2.316 | p# = 0.461, F = 0.783 p = 0.171, F = 1.872 |
| FAD affective responsiveness | p# = 0.288, F = 1.162 p = 0.454, F = 0.573 | p# = 0.216, F = 1.585 p = 0.644, F = 0.217 | p# = 0.798, F = 0.067 p = 0.288, F = 1.186 | p# = 0.861, F = 0.031 p = 0.360, F = 0.882 | p# = 0.264, F = 1.305 p = 0.931, F = 0.008 | p# = 0.624, F = 0.247 p = 0.991, F = 0.000 | p# = 0.317, F = 1.183 p = 0.492, F = 0.688 | p# = 0.891, F = 0.092 p = 0.517, F = 0.640 |
| FAD affective involvement | p# = 0.508, F = 0.447 p = 0.022, F = 5.710 | p# = 0.729, F = 0.122 p = 0.041, F = 4.516 | p# = 0.585, F = 0.307 p = 0.258, F = 1.352 | p# = 0.780, F = 0.080 p = 0.223, F = 1.595 | p# = 0.229, F = 1.524 p = 0.890, F = 0.020 | p# = 0.914, F = 0.012 p = 0.689, F = 0.165 | p# = 0.277, F = 1.325 p = 0.271, F = 1.325 | p# = 0.847, F = 0.166 p = 0.280, F = 1.294 |
| FAD general functioning | p# = 0.439, F = 0.611 p = 0.531, F = 0.400 | p# = 0.394, F = 0.744 p = 0.562, F = 0.343 | p# = 0.600, F = 0.283 p = 0.289, F = 1.183 | p# = 0.268, F = 1.308 p = 0.270, F = 1.294 | p# = 0.987, F = 0.000 p = 0.364, F = 0.857 | p# = 0.180, F = 1.919 p = 0.388, F = 0.778 | p# = 0.698, F = 0.354 p = 0.251, F = 1.433 | p# = 0.315, F = 1.196 p = 0.320, F = 1.178 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Ipsen, I.S.; Csillag, C.; Austin, S.F.; Vinberg, M. Who Benefits from Family Psychoeducation for Relatives of Adults with Major Depressive Disorder? Findings from a Randomized Controlled Trial. J. Clin. Med. 2026, 15, 4118. https://doi.org/10.3390/jcm15114118
Ipsen IS, Csillag C, Austin SF, Vinberg M. Who Benefits from Family Psychoeducation for Relatives of Adults with Major Depressive Disorder? Findings from a Randomized Controlled Trial. Journal of Clinical Medicine. 2026; 15(11):4118. https://doi.org/10.3390/jcm15114118
Chicago/Turabian StyleIpsen, Ida Schou, Claudio Csillag, Stephen Fitzgerald Austin, and Maj Vinberg. 2026. "Who Benefits from Family Psychoeducation for Relatives of Adults with Major Depressive Disorder? Findings from a Randomized Controlled Trial" Journal of Clinical Medicine 15, no. 11: 4118. https://doi.org/10.3390/jcm15114118
APA StyleIpsen, I. S., Csillag, C., Austin, S. F., & Vinberg, M. (2026). Who Benefits from Family Psychoeducation for Relatives of Adults with Major Depressive Disorder? Findings from a Randomized Controlled Trial. Journal of Clinical Medicine, 15(11), 4118. https://doi.org/10.3390/jcm15114118

